"UMC Health System in Lubbock, Texas is a public, non-profit 500-bed hospital. UMC Health System is owned by the taxpayers of Lubbock County. It serves as the primary teaching hospital for the Texas Tech University Health Sciences Center (TTUHSC). UMC had the first Level 1 Trauma Center in West Texas, the John A. Griswold Trauma Center, and it is still the only Level 1 Trauma Center in the region. UMC's Timothy J. Harnar Burn Center is the only Burn Center in the region. UMC's Children's Hospital is a part of the Children's Miracle Network and includes a pediatric intensive care unit and a neonatal intensive care unit."

During the past decade, University Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 4 trials, followed by "Texas Tech University Health Sciences Center" with 4 trials sponsored, "Anesiva, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "NSABP Foundation Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (3 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Burns" (2 trials), "ATM Gene Mutation" (1 trials) and "ATR Gene Mutation" (1 trials). Many other conditions were trialed in "University Medical Center" in a lesser frequency.

Most popular intervention types in "University Medical Center" are "Drug" (8 trials), "Other" (4 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "Ipilimumab" (2 trials), "Nivolumab" (2 trials), "Pharmacological Study" (2 trials) and "Talazoparib" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Medical Center". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

University Medical Center has several departments that took part in Clinical trials: "UMC Cancer Center / UMC Health System" - 81 trials